Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice

Journal of Virology

Volumn 72, Issue 2, 1998, Pages 1704-1708

  Larsen, Diane L ^a   Dybdahl Sissoko, Naomi ^a   Mcgregor, Martha W ^a   Drape, Robert ^b   Neumann, Veronica ^b   Swain, William F ^b   Lunn, D Paul ^a   Olsen, Christopher W ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b PowderJect Vaccines Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BIOLISTIC TRANSFORMATION; CONTROLLED STUDY; INFECTION PREVENTION; INFLUENZA VIRUS A; INTRADERMAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION;

EID: 0031951171     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.2.1704-1708.1998     Document Type: Article

References (47)

1. Aarden, L. A., E. R. De Groot, O. L. Schapp, and P. M. Lansdorp. 1987. Production of hybridoma growth factor by monocytes. Eur. J. Immunol. 17:1411-1416.
2. Arden, N. H., N. J. Cox, and L. B. Schonberger. 1996. Prevention and control of influenza. Morbid. Mortal. Weekly Rep. 45:1-24.
3. Bender, B. S., C. A. Rowe, S. F. Taylor, L. S. Wyatt, B. Moss, and P. A. Small, Jr. 1996. Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza. J. Virol. 70:6418-6424.
4. Chow, Y.-H., W.-L. Huang, W.-K. Chi, Y.-D. Chu, and M.-H. Tao. 1997. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J. Virol. 71:169-178.
5. Clements, M. L., S. O'Donnell, M. M. Levine, R. M. Chanock, and B. R. Murphy. 1983. Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect. Immun. 40:1044-1051.
6. Deck, R. R., C. M. DeWitt, J. J. Donnelly, M. A. Liu, and J. B. Ulmer. 1997. Characterization of humoral immune responses induced by an influenza hemaaglutinin DNA vaccine. Vaccine 15:71-78.
7. Donnelly, J. J., J. B. Ulmer, and M. A. Liu. 1994. Immunization with DNA. J. Immunol. Methods 176:145-152.
8. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1993. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. USA 90: 11478-11482.
9. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1995. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17:79-83.
10. Hannant, D., J. A. Mumford, and D. M. Jessett. 1988. Duration of circulating antibody and immunity following infection with equine influenza virus. Vet. Rec. 122:125-128.
11. Haynes, J. R., D. E. McCabe, W. F. Swain, G. Widera, and J. T. Fuller. 1996. Particle-mediated nucleic acid immunization. J. Biotechnol. 44:37-42.
12. Hengge, U. R., E. F. Chan, R. A. Foster, P. S. Walker, and J. C. Vogel. 1996. Cytokinc gene expression in epidermis with biological effects following injection of naked DNA. Nat. Genet. 10:161-166.
13. Holmgren, J., C. Czerkinsky, N. Lycke, and A.-M. Svennerholm. 1992. Mucosal immunity: implications for vaccine development. Immunobiology 184: 157-179.
14. 13a. Larsen, D. L., et al. Unpublished results.
15. Liew F. Y., S. M. Russell, G. Appleyard, C. M. Brand, and J. Beale. 1984. Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivity. Eur. J. Immunol. 14:350-356.
16. Lin, R., P. E. Tarr, and T. C. Jones. 1995. Present status ot the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin. Infect. Dis. 21:1439-1449.
17. Lofthouse, S. A., A. E. Andrews, A. D. Nash, and V. M. Bowles. 1995. Humoral and cellular responses induced by intradermally administered cytokine and conventional adjuvants. Vaccine 13:1131-1137.
18. Lunn, D. P., et al. Unpublished results.
19. 16b. Macklin, M. D., D. McCabe, M. W. McGregor, V. Neumann, T. Meyer, R. Callan, V. S. Hinshaw, and W. F. Swain. 1998. Immunization of pigs with a particle-mediated DNA vaccine to influenza A virus protects against challenge with homologous virus. J. Virol. 72:1491-1496.
20. McGhee, J. R., and H. Kiyono. 1992. Mucosal immunity to vaccines: current concepts for vaccine development and immune response analysis, p. 3-12. In J. E. Ciardi (ed.), Genetically engineered vaccines. Plenum Press, New York, N.Y.
21. Mostov, K. E. 1994. Transepithelial transport of immunoglobulins. Annu. Rev. Immunol. 12:63-84.
22. Mumford, J. 1992. Progress in the control of equine influenza, p. 207-217. In W. Plowright, P. D. Rossdale, and J. F. Wade (ed.), Equine infectious diseases VI. Proceedings of the Sixth International Conference. R and W Publications, Newmarket, •••.
23. Murphy, B. R., and R. G. Webster. 1996. Orthomyxoviruses, p. 1397-1445. In B. N. Fields D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Field's virology. Lippincott-Raven Publishers, Philadelphia, Pa.
24. Noll, A., and I. B. Autenrieth. 1996. Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect. Immun. 64:2955-2961.
25. Olsen, C. W., M. W. McGregor, A. J. Cooley, B. Schantz, B. Hotze, and V. S. Hinshaw. 1993. Antigenic and genetic analysis of a recently isolated H1N1 swine influenza virus. Am. J. Vet. Res. 54:1630-1636.
26. Olsen, C. W., M. W. McGregor, N. Dybdahl-Sissoko, B. R. Schram, K. M. Nelson, D. P. Lunn, M. D. Macklin, W. F. Swain, and V. S. Hinshaw. 1997. Immunogenicity and efficacy of baculovirus-expressed and DNA-based equine influenza virus hemagglutinin vaccines in mice. Vaccine 15:1149-1156.
27. Pertmer, T. M., M. D. Eisenbraun, D. McCabe, S. K. Prayaga, D. F. Fuller, and J. R. Haynes. 1995. Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA. Vaccine 13:1427-1430.
28. Pockley, A. G., and P. C. Montgomery. 1991. In vivo adjuvant effect of interleukins 5 and 6 on rat tear IgA antibody responses. Immunology 73:19-23.
29. Ramsay, A. J., A. J. Husband, I. A. Ramshaw, S. Bao, K. I. Matthaei, G. Koehler, and M. Kopf. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264:561-563.
30. Ramsay, A. J., and M. Kohonsen-Corish. 1993. Interleukin-5 expressed by a recombinant virus vector enhances specific mucosal IgA responses in vivo. Eur. J. Immunol. 23:3141-3145.
31. Reed, L. J., and H. Muench. 1938. Simple method of estimating 50 percent endpoints. Am. J. Hyg. 27:493-497.
32. Renegar, K. B., and P. A. Small, Jr. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972-1978.
33. Renegar, K. B., and P. A. Small, Jr. 1991. Immunoglobulin A mediation of murine nasal anti-influenza virus immunity. J. Virol. 65:2146-2148.
34. Sakaguchi, M., H. Nakamura, K. Sonoda, F. Hamada, and K. Hirai. 1996. Protection of chickens from Newcastle disease by vaccination with a linear plasmid DNA expressing the F protein of Newcastle disease virus. Vaccine 14:747-752.
35. 31a. Soboll, G., et al. Unpublished results.
36. Sun, W. H., J. K. Burkholder, J. Sun, J. Culp, J. Turner, X. G. Lu, T. D. Pugh, W. B. Ershler, and N.-S. Yang. 1995. In vivo cytokine gene transfer by gene gun reduces tumor growth in mice. Proc. Natl. Acad. Sci. USA 92: 2889-2893.
37. Swain, W. F., M. D. Macklin, V. Neumann, D. E. McCabe, R. Drape, J. T. Fuller, G. Widera, M. W. McGregor, R. J. Callan, and V. Hinshaw. 1997. Manipulation of immune responses via particle-mediated polynucleotide vaccines. Behring. Inst. Res. Commun. 98:73-78.
38. Takase, H., Y. Murakami, A. Endo, and T. Ikeuchi. 1996. Antibody responses and protection in mice immunized orally against influenza virus. Vaccine 14:1651-1656.
39. Tamura, S., H. Funato, Y. Hirabayashi, Y. Suzuki, T. Nagamine, C. Aizawa, and T. Kurata. 1991. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur. J. Immunol. 21:1337-1344.
40. Traub-Dargatz, J. L., M. D. Salman, and J. L. Voss. 1991. Medical problems of adult horses, as ranked by equine practitioners. J. Am. Vet. Med. Assoc. 198:1745-1747.
41. Ulmer, J. B., R. R. Deck, C. M. DeWitt, A. Friedman, J. J. Donnelly, and M. A. Liu. 1994. Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541-1544.
42. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, V. J. Dwarki, S. H. Gromkowski, R. R. Deck, C. M. DeWitt, A. Friedman, L. A. Hawe, K. R. Leander, D. Martinez, H. C. Perry, J. W. Shiver, D. L. Montgomery, and M. A. Liu. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
43. Van Snick, J. 1990. Interleukin-6: an overview. Annu. Rev. Immunol. 8:253-278.
44. Webster, R. G., E. F. Fynan, J. C. Santoro, and H. Robinson. 1994. Protection of ferrets against influenza challenge with a DNA vaccine to the haemagglutinin. Vaccine 12:1495-1498.
45. Whalen, R. G. 1996. DNA vaccines for emerging infectious diseases: what if? Emerg. Infect. Dis. 2:168-175.
46. Xiang, Z., and H. C. Ertl. 1995. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135.
47. Yankauckas, M. A., J. E. Morrow, S. E. Parker, A. Abai, G. H. Rhodes, V. J. Dwarki, and S. H. Gromkowski. 1993. Long-term anti-nucleoprotein cellular and humoral immunity is induced by intramuscular injection of plasmid DNA containing the NP gene. DNA Cell Biol. 12:771-776.